Edited course of biomedical research: leaping forward with CRISPR

Published on Nov 1, 2017in Pharmacological Research5.57
· DOI :10.1016/j.phrs.2017.09.008
Patrick J. Collins1
Estimated H-index: 1
Christopher M. Hale13
Estimated H-index: 13
Han Xu1
Estimated H-index: 1
Abstract Within the short few years since the report of its application in precise genome editing, CRISPR technology has become the method of choice to modify and modulate gene expression in biomedical research and therapeutic development. Subsequently, a variety of research, diagnostic, and therapeutic tools have been developed based upon CRISPR’s mechanism of action. Such tools have helped to deepen the understanding of fundamental biology and broaden the horizon in the search for treatments for diseases that have been considered hard or impossible to cure. As CRISPR technology advances closer to clinical applications, its short comings are becoming more apparent, thus creating opportunities to improve the technology’s efficacy, specificity, and safety profile in this setting. We will summarize the current status of CRISPR technology and discuss its future impact in this review.
  • References (85)
  • Citations (3)
#1Emmanouil Metzakopian (Wellcome Trust Sanger Institute)H-Index: 9
#2Alex Strong (Wellcome Trust Sanger Institute)H-Index: 4
Last.Jacob Lamberth (Merck KGaA)H-Index: 1
view all 15 authors...
#1Sylvain Rama (AMU: Aix-Marseille University)H-Index: 8
#2Mickaël Zbili (AMU: Aix-Marseille University)H-Index: 5
Last.Dominique Debanne (AMU: Aix-Marseille University)H-Index: 33
view all 8 authors...
#1Dong Niu (ZJU: Zhejiang University)H-Index: 3
#2Hong-Jiang Wei (Yunnan Agricultural University)H-Index: 4
Last.Ellen Shrock (Harvard University)H-Index: 5
view all 22 authors...
#1Hong Ma (Oregon National Primate Research Center)H-Index: 27
#2Nuria Marti-Gutierrez (OHSU: Oregon Health & Science University)H-Index: 1
Last.Riffat Ahmed (OHSU: Oregon Health & Science University)H-Index: 10
view all 31 authors...
#1Ana M. Moreno (UCSD: University of California, San Diego)H-Index: 3
#2Prashant Mali (UCSD: University of California, San Diego)H-Index: 29
#1Lichun Tang (Protein Sciences)H-Index: 1
#2Yanting Zeng (Guangzhou Medical University)H-Index: 1
Last.Xiaowei Li (NU: Nanjing University)H-Index: 1
view all 11 authors...
Cited By3
#1Olivier Humbert (Fred Hutchinson Cancer Research Center)H-Index: 5
#2George S. Laszlo (Fred Hutchinson Cancer Research Center)H-Index: 11
Last.Hans-Peter Kiem (UW: University of Washington)H-Index: 14
view all 10 authors...
#1S. Morgani (Medical Research Council)H-Index: 3
#2Nestor Saiz (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 9
Last.Anna-Katerina Hadjantonakis (Cornell University)H-Index: 55
view all 10 authors...
View next paperThe bright side of synthetic biology and Crispr